Search Submit Your Manuscript

Become A Member

  1. Home
  2. September 2020
  3. 1. Microalbuminuria in Patients with Essential Hypertension
Article Image
Admin

1. Microalbuminuria in Patients with Essential Hypertension

Salma Kadir, Musarat Jehan Baloch and Nazir Ahmed Memon

ABSTRACT

Objective: To determine the microalbuminuria in patients with essential hypertension.

Study Design: Cross-sectional multidisciplinary study.

Place and Duration of Study: This study was conducted at the Tertiary Care Hospitals and the data was also gained from private clinics for six months during 2018-2019.

Materials and Methods: All the patients of 30-70 years of age and either gender, having hypertension (systolic blood pressure -SBP ≥140 mmHg and/ or diastolic blood pressure - DBP of ≥90 mmHg) were recruited and enrolled in the study. Blood pressure was measured two times at 5 minutes interval while the mean arterial pressure (MAP) was also calculated. The urinary examination was done among relevant individuals for microalbuminuria by collection of urine specimen and the micro albumin: creatinine ratio <30mg/g considered as normal buminuric while between 30-300mg/g was microalbuminuria whereas the frequency / percentages (%) and means ±SD computed for study variables.

Results: During 6 month study period total 120 patients were explored and study. The mean ± SD for age (years) of population was 52.31±6.62. Regarding gender, male 78 (65%) and 42 females (35%), residence as urban 48 (40%) and rural 72 (60%), family history of hypertension 53 (44.2%), diabetes mellitus 84 (70%), obesity 55 (45.8%) and microalbuminuria 79 (65.8%).

Conclusion: The presence of microalbuminuria in hypertensive individuals shows positive association and should be considered as timely screening tool for microalbuminuria in patients with essential hypertension.

Key Words: Hypertension, microalbuminuria and proteinuria.

Citation of article: Kadir S, Baloch MJ, Memon NA. Microalbuminuria in Patients with Essential Hypertension. Med Forum 2020;31(9):2-4.